-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Infinity Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Infinity Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$9.96M, a 16.9% increase year-over-year.
- Infinity Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$40.9M, a 12.5% increase year-over-year.
- Infinity Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.4M, a 1.97% increase from 2021.
- Infinity Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.3M, a 11.8% decline from 2020.
- Infinity Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$40.5M, a 14% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)